NexImmune Management
Management criteria checks 0/4
Key information
Kristi Jones
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 62.3% |
| CEO tenure | 2.2yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.8yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
NexImmune (NASDAQ:NEXI) Will Have To Spend Its Cash Wisely
Sep 07
Neximmune GAAP EPS of -$0.69 misses by $0.01
Aug 15NexImmune gains aftermarket on IND clearance for NEXI-003 to treat HPV-related cancers
Jul 14NexImmune: Selling For Under Cash Value
May 31Here's Why We're A Bit Worried About NexImmune's (NASDAQ:NEXI) Cash Burn Situation
May 26We're Keeping An Eye On NexImmune's (NASDAQ:NEXI) Cash Burn Rate
Dec 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$675k | -US$32m |
| Sep 30 2023 | n/a | n/a | -US$44m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$57m |
| Dec 31 2022 | US$2m | US$512k | -US$63m |
| Sep 30 2022 | n/a | n/a | -US$61m |
| Jun 30 2022 | n/a | n/a | -US$61m |
| Mar 31 2022 | n/a | n/a | -US$57m |
| Dec 31 2021 | US$2m | US$363k | -US$51m |
| Sep 30 2021 | n/a | n/a | -US$45m |
| Jun 30 2021 | n/a | n/a | -US$39m |
| Mar 31 2021 | n/a | n/a | -US$35m |
| Dec 31 2020 | US$397k | US$308k | -US$33m |
| Sep 30 2020 | n/a | n/a | -US$30m |
| Dec 31 2019 | US$564k | US$298k | -US$23m |
CEO
Kristi Jones (60 yo)
2.2yrs
Tenure
US$1,082,816
Compensation
Ms. Kristi Jones, R.P.H. serves as Chief Executive Officer, President and Director at NexImmune, Inc. since February 2022 and served as its Chief Operating Officer from March 2018 until February 2022. She...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.2yrs | US$1.08m | 0.21% $ 10.0k | |
| Chief Scientific Officer | 2yrs | US$631.06k | 0.023% $ 1.1k | |
| Consultant | less than a year | US$1.35m | 0% $ 0 | |
| Interim CFO & Principal Accounting Officer | no data | no data | no data | |
| Head of Human Resources | no data | no data | no data | |
| Senior Vice President of Molecular Engineering & Protein Design | 6.9yrs | no data | no data | |
| Chief Medical Officer | 3.3yrs | US$2.91m | 0% $ 0 | |
| Senior Vice President of Corporate Affairs | 3yrs | no data | no data | |
| Senior Vice President of Translational Science | 2.8yrs | no data | no data | |
| Head of Business Development | 2.8yrs | no data | no data |
2.8yrs
Average Tenure
60yo
Average Age
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.2yrs | US$1.08m | 0.21% $ 10.0k | |
| Independent Chairman of the Board | 4.4yrs | US$102.00k | 11.97% $ 559.6k | |
| Chair of Autoimmune & Infectious Disease Scientific Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 7.2yrs | US$62.50k | 0% $ 0 | |
| Independent Director | 7.3yrs | US$64.00k | 0.037% $ 1.7k | |
| Chief Scientific Advisor | 2.9yrs | no data | no data | |
| Independent Director | 7.3yrs | US$57.50k | 0.23% $ 10.7k | |
| Independent Director | 3.3yrs | US$44.00k | 3.23% $ 150.8k | |
| Co-Chairman of Scientific Advisory Board | 12.3yrs | no data | no data | |
| Independent Director | 7.3yrs | US$62.50k | 0.081% $ 3.8k | |
| Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.9yrs | no data | no data |
3.8yrs
Average Tenure
60yo